Good morning, in this edition of Archer’s Newsletter, we highlight a major tech development breakthrough for the Company and introduce you to our newly established global semiconductor supply-chain link with GlobalFoundries.
Archer’s core business involves the development of our 12CQ quantum chip and biochip technologies, which are underpinned by the Company’s nanofabrication capabilities. As you would appreciate, our work is complex.
Achieving sub-10 nanometre lithographic processing of biochip components was a great outcome – it’s leading edge in the semiconductor industry and one that demonstrates the world-class capabilities of our pioneering team.
At Archer, we take an over-the-horizon view of what we do – we must anticipate greater involvement in the global semiconductor supply chain. To scale the fabrication of Archer’s chip technologies, the Company will need to work with industrial-scale manufacturers.
Archer is now positioned to leverage the expertise and capabilities of GlobalFoundries, a tier-one semiconductor manufacturer, to accelerate the development of our 12CQ quantum chip technology.
We have a clear and specific focus at Archer to methodically advance our 12CQ quantum chip and biochip technologies, and I look forward to updating you on our progress.
Dr Mohammad Choucair, FRACI FRSN GAICD
Chief Executive Officer
Archer Materials Limited (ASX: AXE)
Designed by Aaron Knight.